Patients advised to keep taking Inegy cholesterol therapy despite cancer link study - The Times 4th September 2008

Patients have been advised to carry on taking an anti-cholesterol treatment despite research that suggested it may be linked to higher cancer rates. Inegy, a therapy that combines simvastatin with another drug called ezetimibe, was linked to slightly raised levels of a variety of cancers in an international study whose results were published in the New England Journal of Medicine.

Link to Article

Additional Stories

We need a change of heart on statins - The Telegraph 4th September 2008

Cholesterol drug cancer warning' - BBC Health News 3rd September 2008